Leaders in the pharma industry public
[search 0]
More

Download the App!

show episodes
 
American Healthcare Entrepreneurs and Execs you might want to know. Talking. Relentless Health Value is a weekly interview podcast hosted by Stacey Richter, a healthcare entrepreneur celebrating fifteen years in the business side of healthcare. This show is for leaders in pharma, devices, payers, providers, patient advocacy and healthcare business. It's for health industry innovators, entrepreneurs or wantrepreneurs or intrapreneurs. Relentless Healthcare Value is the show for you if you wan ...
 
The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Hosted by Jeff Stewart, a long-time industry consultant who has advised biopharma leaders on licensing, mergers and acquisitions, pricing and market access, commercialization and go-to-market strategies, each episode explores the challenges and considerations involved wi ...
 
The podcast from statisticians for statisticians to have a bigger impact at work. This podcast is set up in association with PSI - Promoting Statistical Insight. This podcast helps you to grow your leadership skills, learn about ongoing discussions in the scientific community, build you knowledge about the health sector and be more efficient at work. This podcast helps statisticians at all levels with and without management experience. It is targeted towards the health, but lots of topics wi ...
 
Together with prominent Pharmaceutical industry leaders, Impetus Digital is covering topics around what it means to be an effective leader in Pharma today. We are also exploring topics related to digital transformation, patient-centricity, industry partnerships, customer engagement, diversity in Pharma, systems thinking, current healthcare challenges, environmental and supply chain concerns, and the myriad of ways that Pharma is working to collectively and positively disrupt healthcare. At I ...
 
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by BioProcess Online and brought to you by Cytiva, former ...
 
Digital Health Today features the innovators, leaders and pioneers reshaping health and wellness. From patients and clinicians, to inventors and investors, we speak with guests from around the world to share their insights, experience and knowledge from the front lines of health tech innovation. Tune in, subscribe and become a part of the digital health community. Proud Member: Health Podcast Network.
 
In this audio program, you meet movers, shakers and innovators in the eyeforpharma network who transform the pharmaceutical sector. Our mission is to make pharma more open and valued. We’re creating a movement for industry leaders who prioritize value for patients and healthcare. To get involved in one of our programs and to discover many other valuable resources, join us via social.eyeforpharma.com or get in touch directly at podcast.us@eyeforpharma.com. Thanks for tuning in!
 
We believe Mission and Margin is the business of healthcare. Business of Healthcare (BOH) interviews feature innovations sustainably improving healthcare Mission & Margin. Each discussion includes a healthcare executive and innovator concentrating on the same problem. Think “Nightline” or “How I Built This” just for healthcare. Recent guests have included Bernadette Spong, Chief Financial Officer, Orlando Health, Paul Kusserow, President & CEO, Amedisys, Blake Marggraff, Founder & Chief Exec ...
 
Tim is Stockhead’s resident Health and Biotech expert with his weekly column “Dr Boreham’s Crucible”. Tim was the author of the Criterion column in The Australian newspaper for well over 10 years and has more than three decades’ experience of business reporting across three major publications. In his weekly “The Health Kick Podcast” Tim will interview Australia’s leading Health and Biotech industry leaders, bringing his own unique insight and perspective into the world of health and drug dis ...
 
RCA Radio covers the latest news and challenges in regulatory, compliance, and quality assurance facing the medical device, pharmaceutical, and biologic industries. Each episode, join Regulatory Compliance Associates® Inc. (RCA) and industry thought leaders as we navigate the issues that matter to you most.
 
Solebury Trout partners with private and public companies across sectors, helping management teams tackle complex investor relations challenges, capitalize on corporate communications opportunities, access the market and prepare for capital raising. More than 60 professionals with expertise in investor relations, equity research, portfolio management, private equity, investment banking and corporate communications work at Solebury Trout. The company was formed through the combination of Sole ...
 
Welcome to The Launchpad Podcast, powered by ACTO, Omnichannel Education for Life Sciences. We discuss commercialization strategies for drugs and devices across the globe, that challenge the status quo. We also highlight change agents working to disrupt life sciences and their strategies for success in the complex post-market promotion landscape.
 
The Prospect Group is a leading global firm specializing in media, research, and consulting. We meet, and discuss the most relevant economic issues with, hundreds of the world’s leading business executives, political elites, and other influential personalities from a cross-section of industries and countries. Watch video interviews from and/or about Malaysia.
 
Loading …
show series
 
In this edition of Device Week, Medtech Insight’s Marion Webb discusses the huge number of digital health deals being done at the moment, including exciting developments in the SPAC space. UK-based reporter Barnaby Pickering talks about Angle, a British liquid diagnostics company that has developed a novel approach to liquid diagnostics. - Exec Cha…
 
HBW Insight talks to the Global Self Care Federation's director general, Judy Stenmark, about the impact of pandemic on global self-care industry, as well as what GSCF is doing to promote self-care in the wake of the pandemic. Marking International Self-Care Day (24 July) Stenmark tells HBW Insight's Senior Editor (EU) David Ridley about the GSCF's…
 
Davinderpreet Mangat, Pamela Spicer, Jessica Merrill, and Catherine Kelly discuss the approval of Aduhelm in Alzheimer’s disease.Topics covered include:• Drug development and approval - 01:45• Pricing and commercial potential - 15:12• National reimbursement processes - 30:55Supporting links:• Datamonitor’s Alzheimer’s Disease Analysis report - http…
 
In this health care podcast, I’m interviewing John Marchica, who is the CEO at Darwin Research Group. Starting last year in the middle of the worst of the COVID pandemic, Darwin Research Group conducted a study about what was going on at health systems or integrated delivery networks (IDNs), and they’ve updated it every quarter since then. The goal…
 
In this month’s podcast, Medtech Insight's Reed Miller, Marion Webb and Barnaby Pickering offer a recap of Medtech Insight’s digital health coverage in June, including the record-breaking H1 digital health funding, a recap of ADA 2021 and updates on telehealth legislation.Medtech Insight articles addressing topics discussed in this episode:Quanta R…
 
Interview with Irene de la Torre Arenas Listen while we discuss the following points: Connection between paper world and digital world What is possible in the digital world Additional data Background information Exploration of data (interactivity) Augmented reality (show psoriasis on your skin) Animated charts Scrolly-telling Capture information ab…
 
As leaders at Diamyd Medical made plans to manufacture clinical supply of therapies aimed at preserving and restoring insulin production in Type 1 diabetes patients, outsourced production was on the table. Then, the company doubled down on its intentions and built out its own manufacturing facility. On this week's episode of The Business of Biotech…
 
In this week’s podcast, EU regulatory editor Amanda Maxwell walks us through the latest news and documents coming out of the European Union’s efforts to revamp its medical device and diagnostics rules and makes some predictions about what we can expect to see going forward.By Informa
 
Today it’s our pleasure to introduce you to Don Schmincke. Don is a former MIT and John Hopkins Institute, researcher-turned organizational strategic development consultant. He's the guy CEOs bring in when all the “experts” fail. Don has written two bestselling management books, "High Altitude Leadership" and "Code of the Executive," and is an in-d…
 
In a recent article in STAT news, TJ Parker, the VP of pharmacy at Amazon and the founder of PillPack, explained that Amazon’s plan to stand out in the pharmacy space is simple: “Better selection, better convenience, and better prices.” He added, “It really is the Amazon playbook.” Better selection, better convenience, better price. The playbook of…
 
In this episode of the Syneos Health Podcast: 2021 Health Trends Edition, we share the latest thinking on the potential for our industry to make healthcare interactions and communications more personal and useful. Many life sciences organizations are quickly moving into that world of right person, right message, right moment messaging and scaling i…
 
Interview with Shanthi Sethuraman Join us while we discuss the following points: What was her motivation for hiring people How did she broaden her scope of work for the company How did she face resistance from people under her Why did she move from one position to another How to lead a team effectively…
 
Kite Pharma Global Head of Technical Operations Chuck Calderaro joins the Business of Biotech for a conversation on a dichotomy in the CAR T-cell supply chain: the inherent source material advantages and subsequent logistical challenges associated with the distribution of cell therapies. Calderaro discusses the implementation of manufacturing autom…
 
In this week’s podcast, Medtech Insight editors Marion Webb and Reed Miller discuss the latest news from the American Diabetes Association conference as well as an interview with Dexcom CEO Kevin Sayer about the company’s strategy in the blood glucose measurement market.The archive of Device Week and the rest of Informa Pharma Intelligence’s podcas…
 
“Scientists Announce Successful Experiment to Bankrupt Mouse That Can’t Afford Cancer Drug.” That’s a recent headline from The Onion, which is, by the way, a funny satire newspaper, if you haven’t heard of it. You could swap out “Cancer Drug” in that headline with “a Trip to the ER”—or pretty much any aspect of health care in this country. No matte…
 
A great story creates a connection, elicits feelings of compassion and empathy and can ultimately influence behavior. The rise of digital platforms have enabled richer, deeper storytelling, driving a greater desire for sharing and connection. How can biopharma companies better leverage their own stories to build trust and engagement with their audi…
 
Interview with Kaspar Rufibach and Jan Beyersmann Join us while we dive deep into the following points: How do you solve the problem about varying follow-up times? What’s so special about the setup of the SAVVY collaboration? Where can people learn more about SAVVY? References: Stegherr et al (2021) Biom J https://doi.org/10.1002/bimj.201900347 Pre…
 
When is the appropriate time for a new life sciences company to wind up the PR machine? What's the difference between public and investor relations, and how do they complement each other? What's newsworthy? What's not? What are the latest tools of the trade in an increasingly social-driven PR practice? What results should you expect, and how are th…
 
In this week’s podcast, senior reporter Ferdous Al-Faruque discusses the most interesting tidbits from his recent interview with US FDA device center chief Jeff Shuren, and managing editor Elizabeth Orr offers updates on what two recent Supreme Court patent decisions could mean for medtech.By Informa
 
If I had a nickel for every guest on this show who went on to achieve wild success … TJ Parker from PillPack three years before they were bought by Amazon. Anyway, let me introduce this show with a clip from the recent podcast (EP325) with Dr. Mai Pham. We were talking about the rampant and very open secret of excessive upcoding in Medicare Advanta…
 
When the pandemic took hold, practices and research sites limited physical access to protect people while health systems and industry partners moved to rapidly scale digital and voice channels to maximize patient connectivity. Regulators and payers joined the cause to reduce friction and fuel reimbursement. As that immediacy and urgency fade, there…
 
At the beginning of the COVID-19 pandemic and in direct response to government advisories limiting nonessential travel, healthcare practitioners (HCPs) were quick to adopt digital platforms for engaging with pharma sales reps. And interestingly, it appears that these virtual engagements are actually increasing the amount of time HCPs spend with the…
 
David Dahan, Ellie Davenport, Tom Tyler and Zachary McLellan discuss the 2021 ASCO conference. Topics covered include:CheckMate 648 trial, Opdivo in Esophageal Cancer - 00:47VISION trial, 177Lu-PSMA-617 in Prostate Cancer – 08:20RELATIVTY-047 trial, Relatlimab and Opdivo in Melanoma – 15:36CARTITUDE-1 trial, Cilta-cel in Multiple Myeloma – 19:45ELE…
 
In this episode, Sam and I talk about the advantages of spending time in the non-clinical areas and other important points: Work on tremendous amount of variety with you can do with non-clinical statistics. Ability to have influence in the organization Be able to build a larger network and improve soft skills Have the love for engineering and physi…
 
In this bonus edition of HBW Insight's new 'Over The Counter' podcast, David Ridley (Senior Editor, EU), speaks to the PAGB's Michelle Riddalls about the association's upcoming Digital Week event (5th to 9th July) and the promise of digitalization for the UK consumer healthcare industry. In this wide-ranging interview, we discuss how digital adopti…
 
When the pandemic hit, Solis Biodyne found its manufacturing capacity stretched to its limit. In short order, it doubled, and then tripled, its manufacturing capacity. Then it doubled, and then tripled, its workforce. Meanwhile, it adopted a host of new platforms to serve the demand of its clients. Drs. Kadri Artma and Angela Vassa join this episod…
 
In this episode of Impetus Digital's Leaders in Pharma podcast, I sit down with Fran Milnes. She is currently the Head of Marketing and Commercial Excellence in Oncology at Novartis. Schedule a meeting with Jessica Masciangelo: https://www.meetwithimpetus.com/ Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/ Impetus Digital Websi…
 
In this edition of Device Week, Medtech Insight's UK-based reporter Barnaby Pickering provides an insight into Procyrion’s novel device for decongesting cardiorenal syndrome patients. US Commercial and R&D manager, Reed Miller, highlights details on Pear Therapeutics’ recent SPAC acquisition, and managing editor, Marion Webb, discusses two companie…
 
You can subscribe to this show two ways. One way is through the iTunes podcast app or your podcast app of choice. That’s a cool way to subscribe because then the show just kind of turns up in your podcast app each week and you can decide to listen to it on the fly. The other way is to subscribe on our Web site. This is more like a newsletter subscr…
 
In this edition of HBW Insight's new 'Over The Counter' podcast, David Ridley (Senior Editor, EU), talks to Canna Consultants' Steve Oliver about the current state of CBD regulation in the UK and European Union. Specifically, we discuss what is going on with the hundreds of CBD novel food applications submitted to the UK Food Standards Agency and w…
 
Loading …

Quick Reference Guide

Copyright 2021 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login